UK Shareholder Meetings Calendar - Next 7 Days Read More
IN BRIEF: Renalytix Teams With University Of Michigan, Pharma Firm Read More
IN BRIEF: Renalytix's KidneyIntelX Study Accepted For Publication Read More
UK EXECUTIVE CHANGE SUMMARY: Diageo Taps Former Bain And Goldman Exec Read More
UK TRADING UPDATE SUMMARY: XLMedia To Sell Finnish Casino Assets Read More
Renalytix AI Proposes Nasdaq Dual-Listing, Pricing Still To Be Decided Read More
Renalytix Confirms Plans For Demerger Of FractalDx Read More
UK TRADING UPDATE SUMMARY: Omega Diagnostics Signs Antibody Test Deal Read More
Renalytix AI Inks KidneyIntelX Provider Network Deal With Three Rivers Read More
UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work Read More
Renalytix Pretax Loss Widens; Mulls AIM Float For FractalDx Unit Read More
EKF Diagnostic Expects Annual Results In Line With Expectations Read More
Renalytix AI Opens New Commercial Testing Facility In US State Of Utah Read More
Renalytix AI Kidney Disease Test Price Becomes Effective In US Read More
Oryx International Growth Fund In First-Half Net Asset Value Rise Read More
Renalytix Notes Medicare's US National Price For KidneyIntelX Test Read More
US Health Insurer CDPHP To Cover Renalytix AI's KidneyIntelX Read More
Renalytix AI Appoints Johns Hopkins Nephrology Director To Board Read More
(Alliance News) - Renalytix AI PLC on Tuesday said it has raised GBP14.0 million through a "significantly" oversubscribed share placing, with strong demand received from existing and new Read More
